Department of Clinical Gene Therapy, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan.
Department of Geriatric and General Medicine, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan.
Hypertens Res. 2020 Mar;43(3):162-167. doi: 10.1038/s41440-019-0357-9. Epub 2019 Nov 14.
The number of people with dementia is rapidly growing along with the aging of society and is becoming a social issue worldwide. The results of recent clinical and basic studies have suggested that vascular risk factors, such as hypertension and diabetes mellitus, affect the pathogenesis of dementia. Cerebrovascular damage due to vascular risk factors directly triggers vascular dementia, and it is becoming more apparent that vascular risk factors also increase the risk of neurodegenerative Alzheimer's disease, which is associated with the accumulation of neurotoxic proteins in the brain. Although disease-modifying therapy for dementia has not yet been established, several studies have shown that the management of vascular risk factors could possibly contribute to reducing the risk of developing dementia, thus making them important targets for dementia prevention. In this article, we review recent findings regarding the relationship between vascular risk factors and dementia, especially focusing on Alzheimer's disease, the underlying molecular mechanisms, and the potential strategies targeting these modifiable risk factors to prevent cognitive decline.
随着社会老龄化,痴呆症患者的数量迅速增加,这已成为全球范围内的一个社会问题。最近的临床和基础研究结果表明,高血压和糖尿病等血管危险因素会影响痴呆症的发病机制。血管危险因素引起的脑血管损伤直接引发血管性痴呆症,而且越来越明显的是,血管危险因素也会增加与脑内神经毒性蛋白积累相关的神经退行性阿尔茨海默病的风险。虽然尚未确立针对痴呆症的疾病修饰疗法,但多项研究表明,血管危险因素的管理可能有助于降低痴呆症的发病风险,因此它们是痴呆症预防的重要目标。本文综述了血管危险因素与痴呆症,特别是阿尔茨海默病之间关系的最新研究发现,重点介绍了潜在的分子机制以及针对这些可改变的危险因素的潜在策略,以预防认知能力下降。